NCT04375787View on ClinicalTrials.gov

Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

June 2, 2020

Study Completion Date

June 2, 2020

Conditions
Coronary Disease
Interventions
DRUG

Atorvastatin

Patients received 80 mg atorvastatin before elective coronary angiography

Trial Locations (1)

71515

Assiut University, Asyut

All Listed Sponsors
lead

Mohamed Abdelfatah

OTHER

NCT04375787 - Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention | Biotech Hunter | Biotech Hunter